Talon Compounding Pharmacy
Form 483 issued October 6, 2021 · San Antonio, Texas
- Inspection
- Sep 23 – Oct 6, 2021
- Investigator
- Camerson E. Moore
- Observations
- 3
- Pages
- 4
- FEI number
- 3009192575
In short: On October 6, 2021, FDA issued a Form 483 with 3 observations to Talon Compounding Pharmacy in San Antonio, Texas (FEI 3009192575) after an inspection that ran Sep 23 – Oct 6, 2021. The investigator was Camerson E. Moore. Most observations concern facilities & equipment.
At a glance
3 of 3 observations on this 483 concern facilities & equipment.
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
The facility design was observed to allow the influx of poor quality air into…
- 02
Observation 2: scanned text, readable in the full document.
- 03
Your firm handled hazardous drug products without adequate containment, segregation, or cleaning of work surfaces and…
This inspection in context
Camerson E. Moore
48 documents · 2014–2026
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in Texas.
The firmTalon Compounding Pharmacy history
All 4 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.42
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Talon Compounding Pharmacy?
FDA listed 3 observations on this Form 483, mostly about facilities & equipment. The opening words of each observation are shown on this page.
Who inspected Talon Compounding Pharmacy?
Camerson E. Moore is named on this Form 483, for the inspection of Sep 23 – Oct 6, 2021. Each investigator has a profile showing what they cite most.
When was Talon Compounding Pharmacy inspected by FDA?
The inspection ran Sep 23 – Oct 6, 2021, and the Form 483 is dated October 6, 2021.
How do I get the full Form 483 for Talon Compounding Pharmacy?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.